Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×

watch

SciClone Pharmaceuticals, Inc.

Sector: Pharmaceutical Preparations Region: CA, United States


Exchange/Ticker: Nasdaq: SCLN


Company Description

SciClone Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer and infectious diseases. The company operates through two segments: China and Rest of the World including United States. It is a pharmaceutical company with a substantial commercial business in China a product portfolio of therapies for oncology, infectious diseases and cardiovascular, urological, respiratory and central nervous system disorders. Its ZADAXIN (thymalfasin) is approved in over 30 countries and may be used for the treatment of hepatitis B (HBV), hepatitis C (HCV), as a vaccine adjuvant, and certain cancers. The company was founded in 1990 and is headquartered in Foster City, CA.

Similar to: Trius Therapeutics, Inc., GW Pharmaceuticals Plc, Columbia Laboratories, Inc.

Featured Company


Cabo Drilling Corp.

New Westminster, BC, CA

Cabo Drilling Corp. is an international mineral and specialty drilling services provider serving the mining industry from Canada,… Learn more →

You may also be interested in:


Columbia Laboratories, Inc.

Livingston, NJ, US

Columbia Laboratories, Inc. develops, manufactures and sells pharmaceutical products. Its pharmaceutical products include CRINONE… Learn more →

GW Pharmaceuticals Plc

Salisbury, WI, GB

GW Pharmaceuticals Plc researches and develops cannabinoid medicines. The companys principal activity is developing and manufacturing… Learn more →

Trius Therapeutics, Inc.

San Diego, CA, US

Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics… Learn more →